Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Regeneus Ltd.
DescriptionAutologous tumor vaccine with the immunostimulant streptavidin
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityActive immunotherapy
Latest Stage of DevelopmentPhase I
Standard IndicationSolid tumors
Indication DetailsTreat advanced solid tumors
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today